Search Within

Christopher Riedl

Formats
  1. Journal Article (44)
  2. Meeting Abstract (12)
  3. Review (2)
  4. Correspondence (1)
  5. Miscellaneous (1)
Groups
  1. Molecular Imaging and Therapy Service (60)
  2. Radiology, Department of (60)
  3. Sloan Kettering Institute Postdocs (29)
  4. Center for Pancreatic Cancer Research (19)
  5. GSK Faculty (19)
  6. Department of Medicine (15)

More Groups

People
  1. Gary Ulaner (21)
  2. Katja Pinker-Domenig (14)
  3. Wolfgang Weber (12)
  4. Yuman Fong (11)
  5. Maxine Jochelson (9)
  6. Heiko Schoder (7)

More People

Years
  1. 2022 (3)
  2. 2021 (3)
  3. 2020 (9)
  4. 2019 (6)
  5. 2018 (6)
  6. 2017 (3)

More Years

Publications
  1. Journal of Nuclear Medicine (15)
  2. European Journal of Nuclear Medicine and Molecular Imaging (7)
  3. Clinical Nuclear Medicine (4)
  4. Journal of Clinical Oncology (4)
  5. Radiology (3)
  6. CardioVascular and Interventional Radiology (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (15)
  2. Springer (14)
  3. Lippincott Williams & Wilkins (6)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Science, Inc. (3)
  6. Radiological Society of North America, Inc. (3)

More Publishers

Results (60)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reproducibility of response assessment in metastatic breast cancer patients with contrast-enhanced CT and FDG PET/CT
    Meeting Abstract

    Lebron, L.; Riedl, C.; Long, N.; Pinker-Domenig, K.; Weber, W.
    European Journal of Nuclear Medicine and Molecular Imaging (2016)

    Fulltext@MSK | Save
  • (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer
    Journal Article

    Ulaner, G. A.; Castillo, R.; Goldman, D. A.; Wills, J.; Riedl, C. C.; Pinker-Domenig, K.; Jochelson, M. S.; Gönen, M.
    European Journal of Nuclear Medicine and Molecular Imaging (2016)

    Fulltext@MSK | Save
  • The impact that number of analyzed metastatic breast cancer lesions has on response assessment by (18)F-FDG PET/CT using PERCIST
    Journal Article

    Pinker, K.; Riedl, C. C.; Ong, L.; Jochelson, M.; Ulaner, G. A.; McArthur, H.; Dickler, M.; Gönen, M.; Weber, W. A.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Molecular imaging of biomarkers in breast cancer
    Journal Article

    Ulaner, G. A.; Riedl, C. C.; Dickler, M. N.; Jhaveri, K.; Pandit-Taskar, N.; Weber, W.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Comparison of 18F-FDG PET/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma
    Journal Article

    Hogan, M. P.; Goldman, D. A.; Dashevsky, B.; Riedl, C. C.; Gönen, M.; Osborne, J. R.; Jochelson, M.; Hudis, C.; Morrow, M.; Ulaner, G. A.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Comparison of FDG-PET/CT with contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients: A retrospective analysis
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M.; Ulaner, G.; Mcarthur, H.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • How does the number of lesions analyzed impact response assessment with PERCIST in breast cancer?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M.; Ulaner, G.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Comparison of SUVmax and SUVpeak for response assessment in stage 4 non-small cell lung cancer (NSCLC) by FDG PET/CT
    Meeting Abstract

    Ong, L.; Rager, O.; Lohrmann, C.; Riedl, C.; Pinker, K.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Mcarthur, H. L.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is response classification with PERCIST in stage IV breast cancer influenced by the number of lesions assessed?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save